Neuralstem Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.35 |
Market Cap |
$6.26 M |
Shares Outstanding |
20.01 M |
Public Float |
17.89 M |
Address |
20271 Goldenrod Lane Germantown Maryland 20876 United States |
Employees | - |
Website | http://www.neuralstem.com |
Updated | 07/08/2019 |
Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. |